Minimal change disease: A "two-hit" podocyte immune disorder?

Pediatric Nephrology

Volumn 26, Issue 4, 2011, Pages 645-649

  Shimada, Michiko ^a   Araya, Carlos ^b   Rivard, Chris ^a   Ishimoto, Takuji ^a   Johnson, Richard J ^a   Garin, Eduardo H ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

CD80; CTLA 4; Nephrotic syndrome; Podocyte; T regulatory cell

Indexed keywords

ACTIN; B7 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ARTICLE; AUTOREGULATION; CELL SHAPE; CYTOKINE PRODUCTION; GLOMERULUS FILTRATION; HUMAN; HYPOTHESIS; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; MINIMAL CHANGE GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD80; CHILD; HUMANS; LYMPHOCYTE ACTIVATION; NEPHROSIS, LIPOID; PODOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79954440266     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1676-x     Document Type: Article

References (33)

1. RJ Shalhoub 1974 Pathogenesis of lipoid nephrosis: a disorder of T-cell function Lancet 2 556 560 1:STN:280:DyaE2M%2Fmt12qsA%3D%3D 10.1016/S0140- 6736(74)91880-7 4140273
2. EH Garin LN Diaz W Mu C Wasserfall C Araya M Segal RJ Johnson 2009 Urinary CD80 excretion increases in idiopathic minimal-change disease J Am Soc Nephrol 20 260 266 1:CAS:528:DC%2BD1MXjtFCrt7s%3D 10.1681/ASN.2007080836 19056875
3. M Abdel-Hafez M Shimada PY Lee RJ Johnson EH Garin 2009 Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis 54 945 953 10.1053/j.ajkd.2009.03.019 19556042
4. J Reiser P Mundel 2004 Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome J Am Soc Nephrol 15 2246 2248 10.1097/01.ASN.0000136312.46464.33 15339973 (Pubitemid 39159324)
5. K Wing Y Onishi P Prieto-Martin T Yamaguchi M Miyara Z Fehervari T Nomura S Sakaguchi 2008 CTLA-4 control over Foxp3+ regulatory T cell function Science 322 271 275 1:CAS:528:DC%2BD1cXht1Slu7%2FJ 10.1126/science.1160062 18845758
6. J Reiser G von Gersdorff M Loos J Oh K Asanuma L Giardino MP Rastaldi N Calvaresi H Watanabe K Schwarz C Faul M Kretzler A Davidson H Sugimoto R Kalluri AH Sharpe JA Kreidberg P Mundel 2004 Induction of B7-1 in podocytes is associated with nephrotic syndrome J Clin Invest 113 1390 1397 1:CAS:528:DC%2BD2cXktlCltrw%3D 15146236 (Pubitemid 39071694)
7. EH Garin W Mu JM Arthur CJ Rivard CE Araya M Shimada RJ Johnson 2010 Urinary CD80 excretion distinguishes minimal change disease from focal segmental glomerulosclerosis Kidney Int 78 296 302 1:CAS:528:DC%2BC3cXovFKgtLo%3D 10.1038/ki.2010.143 20485332
8. M Shimada PY Lee D Wymer C Rivard CA Roncal MA Lanaspa PM Mathieson MA Saleem EH Garin RJ Johnson 2009 CD80 expression in podocytes: role of toll receptors J Am Soc Nephrol 20 569A Abstract FPO2010
9. MF Randolph M Greenfield 1967 Proteinuria. A six-year study of normal infants, preschool, and school-age populations previously screened for urinary tract disease Am J Dis Child 114 631 638 1:STN:280:DyaF1c%2FltFOhsA%3D%3D 6060025
10. MI Marks PN McLaine KN Drummond 1970 Proteinuria in children with febrile illnesses Arch Dis Child 45 250 253 1:STN:280:DyaE3c3gsVOitg%3D%3D 10.1136/adc.45.240.250 5419994
11. RK Alwadhi JL Mathew B Rath 2004 Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection J Paediatr Child Health 40 28 32 1:STN:280:DC%2BD2c7jt1ajuw%3D%3D 10.1111/j.1440-1754.2004.00285.x 14718000 (Pubitemid 38333591)
12. YL Tain TY Chen KD Yang 2003 Implications of serum TNF-beta and IL-13 in the treatment response of childhood nephrotic syndrome Cytokine 21 155 159 1:CAS:528:DC%2BD3sXivFeks78%3D 10.1016/S1043-4666(03)00017-6 12697154 (Pubitemid 36407718)
13. HK Yap W Cheung B Murugasu SK Sim CC Seah SC Jordan 1999 Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse J Am Soc Nephrol 10 529 537 1:STN:280:DyaK1M7ntFKisw%3D%3D 10073603 (Pubitemid 29117634)
14. KW Lai CL Wei LK Tan PH Tan GS Chiang CG Lee SC Jordan HK Yap 2007 Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats J Am Soc Nephrol 18 1476 1485 1:CAS:528:DC%2BD2sXls1Glu78%3D 10.1681/ASN.2006070710 17429054 (Pubitemid 46717514)
15. V Audard F Larousserie P Grimbert M Abtahi JJ Sotto A Delmer F Boue D Nochy N Brousse R Delarue P Remy P Ronco D Sahali P Lang O Hermine 2006 Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature Kidney Int 69 2251 2260 1:STN:280: DC%2BD28zkslSqtw%3D%3D 10.1038/sj.ki.5000341 16672913 (Pubitemid 43882113)
16. BF Skinnider U Kapp TW Mak 2002 The role of interleukin 13 in classical Hodgkin lymphoma Leuk Lymphoma 43 1203 1210 1:CAS:528:DC%2BD38XmvFChsLY%3D 10.1080/10428190290026259 12152987 (Pubitemid 34537964)
17. G Lagrue J Laurent 1983 Allergy and lipoid nephrosis Adv Nephrol Necker Hosp 12 151 175 1:STN:280:DyaL3s7nsFSnuw%3D%3D 6404133
18. W Cheung CL Wei CC Seah SC Jordan HK Yap 2004 Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome Pediatr Nephrol 19 627 632 10.1007/s00467-004-1438-8 15064938 (Pubitemid 38771733)
19. DM Mosser X Zhang 2008 Interleukin-10: new perspectives on an old cytokine Immunol Rev 226 205 218 1:CAS:528:DC%2BD1MXhsFGls7%2FP 10.1111/j.1600-065X.2008.00706.x 19161426
20. C Araya L Diaz C Wasserfall M Atkinson W Mu R Johnson E Garin 2009 T regulatory cell function in idiopathic minimal lesion nephrotic syndrome Pediatr Nephrol 24 1691 1698 10.1007/s00467-009-1214-x 19495805
21. Y Hashimura K Nozu H Kanegane T Miyawaki A Hayakawa N Yoshikawa K Nakanishi M Takemoto K Iijima M Matsuo 2009 Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome Pediatr Nephrol 24 1181 1186 10.1007/s00467-009-1119-8 19189134
22. SY Lee HK Choi KJ Lee JY Jung GY Hur KH Jung JH Kim C Shin JJ Shim KH In KH Kang SH Yoo 2009 The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells J Immunother 32 22 28 1:CAS:528:DC%2BD1cXhsFartrnE 10.1097/CJI.0b013e31818ac2f7 19307990
23. L Le Berre S Bruneau J Naulet K Renaudin F Buzelin C Usal H Smit T Condamine JP Soulillou J Dantal 2009 Induction of T regulatory cells attenuates idiopathic nephrotic syndrome J Am Soc Nephrol 20 57 67 10.1681/ASN.2007111244 19020006
24. CI Sellin JF Jégou J Renneson J Druelle TF Wild JC Marie B Horvat 2009 Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis PLoS One 4 e4948 10.1371/journal.pone. 0004948 19319188
25. WJ Moss JJ Ryon M Monze DE Griffin 2002 Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children J Infect Dis 186 879 887 1:CAS:528:DC%2BD38Xot1GnsLw%3D 10.1086/344230 12232827
26. M Vigna-Perez B Hernández-Castro O Paredes-Saharopulos D Portales-Pérez L Baranda C Abud-Mendoza R González-Amaro 2006 Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study Arthritis Res Ther 8 R83 10.1186/ar1954 16677395
27. M Tokunaga K Saito D Kawabata Y Imura T Fujii S Nakayamada S Tsujimura M Nawata S Iwata T Azuma T Mimori Y Tanaka M Tokunaga K Saito D Kawabata Y Imura T Fujii S Nakayamada S Tsujimura M Nawata S Iwata T Azuma T Mimori Y Tanaka 2007 Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system Ann Rheum Dis 66 470 475 1:CAS:528:DC%2BD2sXkvFeks7w%3D 10.1136/ard.2006.057885 17107983 (Pubitemid 46580466)
28. R Stasi N Cooper G Del Poeta E Stipa M Laura Evangelista E Abruzzese S Amadori 2008 Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab Blood 112 1147 1150 1:CAS:528:DC%2BD1cXpvVOktr8%3D 10.1182/blood-2007-12-129262 18375792
29. RJ Johnson A Hurtado J Merszei B Rodriguez-Iturbe L Feng 2003 Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide Am J Kidney Dis 42 575 581 10.1016/S0272-6386(03)00801-1 12955687 (Pubitemid 37048135)
30. C Faul M Donnelly S Merscher-Gomez YH Chang S Franz J Delfgaauw JM Chang HY Choi KN Campbell K Kim J Reiser P Mundel 2008 The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A Nat Med 14 931 938 1:CAS:528:DC%2BD1cXhtVyms7%2FJ 10.1038/nm.1857 18724379
31. CY Xing MA Saleem RJ Coward L Ni IR Witherden PW Mathieson 2006 Direct effects of dexamethasone on human podocytes Kidney Int 70 1038 1045 1:CAS:528:DC%2BD28XptFClsr8%3D 10.1038/sj.ki.5001655 16837924 (Pubitemid 44344073)
32. FJ Barrat DJ Cua A Boonstra DF Richards C Crain HF Savelkoul R de Waal-Malefyt RL Coffman CM Hawrylowicz A O'Garra 2002 In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J Exp Med 195 603 616 1:CAS:528:DC%2BD38XitV2nu7w%3D 10.1084/jem.20011629 11877483 (Pubitemid 34461505)
33. MA Saleem MJ O'Hare J Reiser RJ Coward CD Inward T Farren CY Xing L Ni PW Mathieson P Mundel 2002 A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression J Am Soc Nephrol 13 630 638 1:CAS:528:DC%2BD38Xit1Wrt74%3D 11856766 (Pubitemid 34183927)